Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.

In a prospective, randomized trial, norfloxacin (400 mg perorally, twice a day) was compared with trimethoprim-sulfamethoxazole (160-800 mg perorally, twice a day) in 45 patients with uncomplicated urinary tract infections. Escherichia coli was the most common isolate. Infections due to Enterobacter...

Full description

Saved in:
Bibliographic Details
Main Authors: Goldstein, E J, Alpert, M L, Ginsberg, B P
Format: Artigo
Language:Inglês
Published: 1985
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC176290/
https://ncbi.nlm.nih.gov/pubmed/3158277
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items